Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer

Andrei Gafita; Hui Wang; Robert Tauber; Calogero D’Alessandria; Wolfgang A. Weber; Matthias Eiber

doi:10.1007/s00259-019-04410-8

Exceptional 4-year response to ¹⁷⁷Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer

Andrei Gafita
, Hui Wang
, Robert Tauber
, Calogero D’Alessandria
, Wolfgang A. Weber
, Matthias Eiber

Department of Nuclear Medicine

Technical University of Munich

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Original language	English
Pages (from-to)	2212-2213
Number of pages	2
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	46
Issue number	10
DOIs	https://doi.org/10.1007/s00259-019-04410-8
State	Published - 1 Sep 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00259-019-04410-8

Cite this

@article{cfebb858a2e741cda09a867d31336d3a,

title = "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer",

author = "Andrei Gafita and Hui Wang and Robert Tauber and Calogero D{\textquoteright}Alessandria and Weber, \{Wolfgang A.\} and Matthias Eiber",

year = "2019",

month = sep,

day = "1",

doi = "10.1007/s00259-019-04410-8",

language = "English",

volume = "46",

pages = "2212--2213",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "10",

}

TY - JOUR

T1 - Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer

AU - Gafita, Andrei

AU - Wang, Hui

AU - Tauber, Robert

AU - D’Alessandria, Calogero

AU - Weber, Wolfgang A.

AU - Eiber, Matthias

PY - 2019/9/1

Y1 - 2019/9/1

UR - https://www.scopus.com/pages/publications/85068836337

U2 - 10.1007/s00259-019-04410-8

DO - 10.1007/s00259-019-04410-8

M3 - Comment/debate

C2 - 31273434

AN - SCOPUS:85068836337

SN - 1619-7070

VL - 46

SP - 2212

EP - 2213

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 10

ER -

Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer

UN SDGs

Access to Document

Other files and links

Cite this

Exceptional 4-year response to ¹⁷⁷Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer